See how Dr. Rafat Abonour is using stem cell transplant earlier in treatment of multiple myeloma to improve patient outcomes. | IU Health | Facebook

3.3K views · 50 reactions | How long would you be hospitalized for teclistamab or talquetamab treatment? Dr. Joseph Mikhael, Chief Medical Officer of the IMF, answers in this short clip. Watch the full Q&A with MM specialist Dr. Joe: https://www.myeloma.org/node/11711 #AsktheIMF | International Myeloma Foundation | Facebook

SARCLISA (isatuximab) is being studied with an on-body injector that delivers the drug subcutaneously over 12-15 minutes—no IV needed. A promising new way to make treatment more convenient! #AskTheIMF | International Myeloma Foundation

9.1K views · 156 reactions | What does early intervention mean for smoldering multiple myeloma (SMM)? IMF Chief Medical Officer Dr. Joseph Mikhael gives his take in this short clip. Watch the full myeloma Q&A with Dr. Joe at https://www.myeloma.org/node/11783 #AsktheIMF #mmsm | International Myeloma Foundation | Facebook

9.6K views · 160 reactions | Smoldering myeloma often appears before patients start showing symptoms of multiple myeloma. Listen to our Dr. Robert Orlowski discuss how smoldering myeloma is detected and how we’re treating it with immunotherapy. #CancerMoonshot #endcancer | MD Anderson Cancer Center | Facebook

Light chain myeloma is the third most common type of myeloma. Read more on symptoms and treatment here. | Healthline